DK0907632T3 - Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser - Google Patents

Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser

Info

Publication number
DK0907632T3
DK0907632T3 DK97923621T DK97923621T DK0907632T3 DK 0907632 T3 DK0907632 T3 DK 0907632T3 DK 97923621 T DK97923621 T DK 97923621T DK 97923621 T DK97923621 T DK 97923621T DK 0907632 T3 DK0907632 T3 DK 0907632T3
Authority
DK
Denmark
Prior art keywords
inhibition
matrix metalloproteases
substituted phenethyl
compounds
phenethyl compounds
Prior art date
Application number
DK97923621T
Other languages
English (en)
Inventor
Donald J Wolanin
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0907632T3 publication Critical patent/DK0907632T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97923621T 1996-05-15 1997-05-12 Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser DK0907632T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64502696A 1996-05-15 1996-05-15
PCT/US1997/007919 WO1997043247A1 (en) 1996-05-15 1997-05-12 Inhibition of matrix metalloproteases by substituted phenethyl compounds

Publications (1)

Publication Number Publication Date
DK0907632T3 true DK0907632T3 (da) 2003-04-07

Family

ID=24587359

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97923621T DK0907632T3 (da) 1996-05-15 1997-05-12 Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser

Country Status (24)

Country Link
EP (1) EP0907632B1 (da)
JP (1) JP3305328B2 (da)
CN (1) CN1124255C (da)
AR (1) AR007100A1 (da)
AT (1) ATE229497T1 (da)
AU (1) AU727899B2 (da)
BR (1) BR9709084A (da)
CA (1) CA2253870C (da)
CO (1) CO5070565A1 (da)
DE (1) DE69717811T2 (da)
DK (1) DK0907632T3 (da)
ES (1) ES2188943T3 (da)
HN (1) HN1997000071A (da)
HR (1) HRP970243B1 (da)
ID (1) ID17424A (da)
PA (1) PA8429801A1 (da)
PE (1) PE66298A1 (da)
PT (1) PT907632E (da)
SV (1) SV1997000037A (da)
TN (1) TNSN97082A1 (da)
TW (1) TW363056B (da)
WO (1) WO1997043247A1 (da)
YU (1) YU18497A (da)
ZA (1) ZA974029B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288063B1 (en) 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
KR20010101325A (ko) 1998-12-30 2001-11-14 빌프리더 하이더 치환된 4-비아릴부티르산 유도체 및 5-비아릴펜탄산유도체의 호흡기 질환 치료용 매트릭스 메탈로프로테아제저해제로서의 용도
EP1031349A1 (en) * 1999-02-25 2000-08-30 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
FR2901320B1 (fr) * 2006-05-17 2008-07-04 Univ Savoie Etablissement Publ Dispositif miniaturise apte a fonctionner comme moteur ou refroidisseur selon un cycle thermodynamique de stirling
US20170119776A1 (en) 2014-04-03 2017-05-04 Bayer Pharma Aktiengesellschaft Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof
US20170114049A1 (en) 2014-04-03 2017-04-27 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases
EP3126339A1 (de) 2014-04-03 2017-02-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
DE2112716A1 (de) * 1971-03-17 1972-10-05 Thomae Gmbh Dr K Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
TNSN97081A1 (fr) 1996-05-15 2005-03-15 Bayer Corp Inhibition des matrices metalloproteinases par 2- (w-aroylkyl) -4-biaryl-4-des acides oxubutyriques

Also Published As

Publication number Publication date
HRP970243B1 (en) 2002-06-30
ID17424A (id) 1997-12-24
JP3305328B2 (ja) 2002-07-22
ES2188943T3 (es) 2003-07-01
EP0907632B1 (en) 2002-12-11
CN1225624A (zh) 1999-08-11
PE66298A1 (es) 1998-10-23
SV1997000037A (es) 1999-01-14
ZA974029B (en) 1998-02-19
YU18497A (en) 1999-11-22
CA2253870C (en) 2004-01-06
EP0907632A1 (en) 1999-04-14
AU727899B2 (en) 2001-01-04
DE69717811T2 (de) 2003-05-28
BR9709084A (pt) 1999-08-03
CA2253870A1 (en) 1997-11-20
PA8429801A1 (es) 2000-05-24
WO1997043247A1 (en) 1997-11-20
ATE229497T1 (de) 2002-12-15
CO5070565A1 (es) 2001-08-28
PT907632E (pt) 2003-04-30
HRP970243A2 (en) 1998-04-30
AR007100A1 (es) 1999-10-13
JPH11510517A (ja) 1999-09-14
CN1124255C (zh) 2003-10-15
TNSN97082A1 (fr) 2005-03-15
TW363056B (en) 1999-07-01
DE69717811D1 (en) 2003-01-23
HN1997000071A (es) 1997-06-18
AU2938597A (en) 1997-12-05

Similar Documents

Publication Publication Date Title
DK0923585T3 (da) Phosphinatbaserede inhibitorer af matrixmetalloproteinaser
DK1064298T3 (da) Inhibitorer af caspaser
MA24215A1 (fr) Composes inhibiteurs de squalene-synthetase
DK0946510T3 (da) Hidtil ukendte forbindelser med analgetisk virkning
ATE334700T1 (de) Refluxinhibitoren
BR9711151A (pt) Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
NO991822D0 (no) Substituerte tricykliske forbindelser
DK0839806T3 (da) Substituerede tricykliske forbindelser
NO20003256L (no) ACE inhibitor-MMP inhibitor kombinasjoner
DK0923530T3 (da) Inhibering af matrixmetalloproteaser med substituerede biaryloxosmörsyrer
BR9707514A (pt) Inibidor de neovascularizacão
LV12207A (lv) Tricikliski savienojumi
NO991823D0 (no) Substituerte tricykliske forbindelser
DK0907632T3 (da) Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser
DE69714228D1 (de) Kristalline metallophosphate
NO20002696D0 (no) Nye forbindelser med cGMP-PDE-inhibitoreffekt
ATE224350T1 (de) Inhibition der matrix metalloproteasen durch 2- (omega-aroylalkyl)-4-biaryl-4-oxobutansäuren
IS5821A (is) Kristalluð form af ósanetant
BR9704110A (pt) Medidor de água composto
DK1019042T3 (da) Forbindelser med anti-første-passagevirkning
FI944396A7 (fi) Kiraalinen polarisaatiomuunnin
DK1131313T3 (da) Enantioselektiv alkylering af tricykliske forbindelser
FI930223A0 (fi) Lietteen levittimen jakolaite